GSK706769

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Arthritis, RheumatoidHealthy SubjectsInfection, Human Immunodeficiency Virus

Phase 1

GSK706769 A First Time in Human Study For Males and Females

TerminatedNCT00539201

GlaxoSmithKlineHealthy Subjects

Start: 2007-09-30End: 2008-02-29Updated: 2010-10-19

GSK706769 Repeat Dose Study

CompletedNCT00711386

GlaxoSmithKlineInfection, Human Immunodeficiency Virus

Start: 2008-05-16End: 2008-09-12Updated: 2017-08-03

Phase 2

A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients

WithdrawnNCT00979771

GlaxoSmithKlineArthritis, Rheumatoid

Start: 2010-02-01End: 2011-04-28Updated: 2024-01-22